Immunosuppression for Immune Checkpoint-related Toxicity Can Cause Pneumocystis Jirovecii Pneumonia (PJP) in Non–small-cell Lung Cancer (NSCLC): A Report of 2 Cases

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical lung cancer 2019-05, Vol.20 (3), p.e247-e250
Hauptverfasser:	Schwarz, Michael, Kocher, Florian, Niedersuess-Beke, Dora, Rudzki, Jakob, Hochmair, Maximilian, Widmann, Gerlig, Hilbe, Wolfgang, Pircher, Andreas
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Carcinoma, Non-Small-Cell Lung - complications Carcinoma, Non-Small-Cell Lung - drug therapy Case report Checkpoint inhibitors Drug Resistance, Neoplasm Drug-Related Side Effects and Adverse Reactions - diagnosis Fatal Outcome Glucocorticoids Humans Immune checkpoint blockade Immunotherapy - adverse effects Immunotherapy - methods Lung Neoplasms - complications Lung Neoplasms - drug therapy Male Nivolumab - adverse effects Nivolumab - therapeutic use Pneumocystis carinii - physiology Pneumonia, Pneumocystis - diagnosis Pneumonia, Pneumocystis - etiology Pneumonitis Programmed Cell Death 1 Receptor - antagonists & inhibitors Respiratory Insufficiency - diagnosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!